top of page

Efforts by Biden to reduce drug use, promote treatment

Writer: Capitol TimesCapitol Times

Photo Credit: Gage Skidmore


As the United States recorded nearly 107,000 overdose deaths during the past 12 months, President Joe Biden sent the first national drug control strategy from his administration to Congress.


Rahul Gupta, White House drug czar, said the strategy will prioritize harm reduction, the first plan of its kind. Its purpose is to prevent drug-related death and illness while actively engaging drug users in treatment and care.


Naloxone should be available over the counter, according to the American Medical Association. Harm reduction programs like fentanyl test strips and clean syringe programs prevent overdoses.


"As a result of the report of a recent congressional commission, harm reduction prevents overdoses and reduces the transmission of infectious diseases," Gupta said.


21 April 2022

Comentarios


Contact us

Letter to Editor-In-Chief
Editor@capitoltimesmedia.com

For Advertising in
Capitol Times Magazine:

ads@capitoltimesmedia.com

Capitol Times magazine Issue 5
Capitol times magazine 9
Capitol times magazine 10

Join our mailing list

FOLLOW US

  • X
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Disclaimer:

The views and opinions expressed in the articles or Interviews published in this magazine are solely those of the respective authors and do not necessarily reflect the official policy or position of the Capitol Times magazine or Capitol Times Media , its editors, or its staff. The authors are solely responsible for the content of their articles. The magazine strives to provide a platform for diverse voices and opinions, and we value the principle of free expression. The magazine assumes no responsibility or liability for any errors or omissions in the content of the articles. In no event shall the Capitol Times magazine or Capitol Times Media be liable for any special, direct, indirect, or incidental damages. Furthermore, the inclusion of advertisements or sponsored content in Capitol Times magazine does not constitute an endorsement or guarantee of the products, services, or views promoted by the advertisers. Readers are encouraged to conduct their own research and exercise caution when making decisions based on advertisements or sponsored content featured in this publication.

Thank you for reading and engaging with our publication. Your feedback is valuable to us as we continue to provide a platform for thought-provoking content and diverse perspectives.

© 2024 by Capitol Times Media LLC - Privacy Policy

bottom of page